Interferon gaining in treatment of ocular surface squamous neoplasia

PHILADELPHIA — Topical interferon is a viable alternative treatment for ocular surface squamous neoplasia, a speaker said here."[A study] speculated that the future of therapy might be to focus on vaccines, antibiotics, antivirals and immune modulators," Carol L. Shields, MD, said at the Wills Eye Institute Annual Conference. "Well, you know what? That future is now. We’re using less and less chemotherapy, radiotherapy and surgical excision for ocular surface squamous neoplasia, and we’re using the top four agents, interferon being the most commonly used. It is slow, it is effective, (Read more...)

Full Story →